You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CC-220

Showing 1 - 25 of 1,304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine
Jan 20, 2023

Healthy Volunteers Trial in Daytona Beach (Iberdomide)

Recruiting
  • Healthy Volunteers
  • Daytona Beach, Florida
    Labcorp Clinical Research Unit, Inc. - Daytona Beach
Jun 9, 2023

Renal Insufficiency Trial in Orlando, Knoxville, San Antonio (Iberdomide)

Recruiting
  • Renal Insufficiency
  • Orlando, Florida
  • +5 more
Dec 16, 2022

Lymphoma, B-Cell Trial in Worldwide (CC-220, Rituximab, Cyclophosphamide)

Recruiting
  • Lymphoma, B-Cell
  • CC-220
  • +6 more
  • Scottsdale, Arizona
  • +26 more
Jul 1, 2022

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 2, 2023

Multiple Myeloma Trial in Worldwide (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Nantes, France
  • +3 more
Aug 16, 2022

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Plasma Cell Myeloma Trial in Rochester (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma
  • CC-220
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jul 28, 2022

Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)

Recruiting
  • Multiple Myeloma
  • Iberdomide plus low-dose cyclophosphamide and dexamethasone
  • Alkmaar, Netherlands
  • +8 more
Oct 5, 2021

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • JCAR017
  • +7 more
  • Duarte, California
  • +17 more
Jan 13, 2023

Multiple Myeloma Trial in Belgium, France, United States (EOS884448, Iberdomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
  • +3 more
Jun 15, 2022

Lymphoma, B-Cell Trial in Worldwide (CC-220, Polatuzumab vedotin, Rituximab)

Withdrawn
  • Lymphoma, B-Cell
  • CC-220
  • +8 more
  • Boston, Massachusetts
  • +26 more
Sep 28, 2021

Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

Recruiting
  • Multiple Myeloma
  • CC-220
  • +4 more
  • Scottsdale, Arizona
  • +126 more
Jan 10, 2023

Hepatic Impairment, Healthy Volunteers Trial in Miami, Orlando, San Antonio (CC-220)

Completed
  • Hepatic Impairment
  • Healthy Volunteers
  • CC-220
  • Miami, Florida
  • +2 more
Jul 23, 2020

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Healthy Trial in Madison (CC-220 0.03 mg, CC-220 0.1 mg, CC-220 0.3 mg)

Completed
  • Healthy
  • CC-220 0.03 mg
  • +6 more
  • Madison, Wisconsin
    Covance Clinical Research Unit
Nov 7, 2019

Sarcoidosis Trial (CC-220 0.3 mg Daily, CC-220 0.6mg Daily, Placebo)

Withdrawn
  • Sarcoidosis
  • CC-220 0.3 mg Daily
  • +2 more
  • (no location specified)
Nov 7, 2019

Lupus Erythematosus, Systemic Trial in Worldwide (CC-220, Placebo)

Completed
Has Results
  • Lupus Erythematosus, Systemic
  • CC-220
  • Placebo
  • Tuscaloosa, Alabama
  • +115 more
Sep 1, 2021

Systemic Lupus Erythematosus Trial in United States (CC-220, Placebo)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • CC-220
  • Placebo
  • Birmingham, Alabama
  • +34 more
Mar 5, 2020

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Orlando, Florida
  • +240 more
Aug 18, 2022

Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Orange, California
  • +270 more
Apr 11, 2023

Psoriasis, Psoriatic Arthritis, Psoriasis Arthropatica Trial in Japan (Apremilast, Placebo)

Completed
Has Results
  • Psoriasis
  • +2 more
  • Fukuoka-shi, Fukuoka, Japan
  • +55 more
Apr 28, 2020

220 Patients With Proximal Femur Fracture

Terminated
  • Thromboembolism
    • Kongsberg, Norway
      Kongsberg Hospital, Vestre Viken Hospital Trust
    Apr 14, 2021